FDA — authorised 21 September 1999
- Status: approved
🇺🇸 Synercid in United States
FDA authorised Synercid on 21 September 1999
Marketing authorisations
FDA — authorised 21 September 1999
- Application: NDA050747
- Marketing authorisation holder: KING PHARMS
- Local brand name: SYNERCID
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 21 September 1999
- Application: NDA050748
- Marketing authorisation holder: KING PHARMS
- Local brand name: SYNERCID
- Indication: INJECTABLE — INTRAVENOUS
- Status: approved
Synercid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Synercid approved in United States?
Yes. FDA authorised it on 21 September 1999; FDA authorised it on 21 September 1999; FDA authorised it on 21 September 1999.
Who is the marketing authorisation holder for Synercid in United States?
Marketing authorisation holder not available in our data.